Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland

2 years ago

COPENHAGEN, Denmark, March 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products,…

PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments

2 years ago

TARRYTOWN, New York, March 13, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing…

Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial

2 years ago

Vancouver, Canada, March 13, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"),…

Liberation Labs Taps Biotech Biomanufacturing Veteran Rhys Dale to Assist with Development & Operations of Flagship Facility

2 years ago

Dale has more than 20 years’ experience in developing and operating biomanufacturing facilities in the U.S. and Internationally Rhys Dale,…

Annual General Meeting 2024 – GN Store Nord A/S

2 years ago

Today, GN Store Nord A/S held its Annual General Meeting. The Annual General Meeting was held in accordance with the…

Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call

2 years ago

DALLAS, March 13, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410

2 years ago

MALVERN, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused…

3Daughters Announces Three New Appointments to Board of Directors

2 years ago

Board will help advance the mission and support development of our game-changing IUD for contraception (3D-001)MANSFIELD, Mass., March 13, 2024…

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

2 years ago

  New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers Active…

Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights

2 years ago

Initiated discussions with FDA regarding accelerated approval pathway for CNM-Au8® for the treatment of ALS with the objective of submitting…